Abstract: This paper develops a novel approach to data-driven optimization of insulin pump treatment parameters in Type 1 Diabetes (T1D). In this approach, records of continuous glucose monitoring (CGM), insulin delivery, and meal records are used (i) to retrospectively estimate samples of the disturbance process that is responsible for daily variability in blood glucose and (ii) to optimize the parameters of functional insulin therapy (i.e. the patient's basal rate, correction factor, and carbohydrate ratio profiles) against the ensemble of estimated disturbance process samples. We illustrate the proposed methodology through retrospective application to data collected in a 30-day field study of patients with T1D, as well as through in silico pre-clinical trials using the FDA-accepted Virginia / Padova Type 1 Simulator.
INTRODUCTION
Insulin therapy is a ubiquitous feature of long-term diabetes management. It is an acute therapeutic requirement for patients with type 1 diabetes (T1D), which is characterized by autoimmune destruction of the pancreatic beta cells. In type 2 diabetes (T2D), which is characterized by progressive insulin resistance, supplemental insulin injections often become necessary after lifestyle changes and insulin-sensitizing drugs fail to adequately manage hyperglycemia. In both cases, careful planning is needed to match appropriate doses and treatment routines to the specific physiological and behavioral characteristics of patients, and this is often the main consideration when patients meet with their endocrinologists. With 25.8 million Americans estimated to have diabetes as of 2013, contributing to an annual cost of $245B (cf. American Diabetes Association (ADA) (2013)), and with the expectation that these numbers will continue to grow significantly over the next decade, there is a clear need for data analytic tools that can support endocrinologist in advising their patients. This paper develops a novel approach to data-driven optimization of insulin pump treatment parameters in T1D. The starting point for our development is the assumption that each treatment day of the patient can be regarded as a batch process reflecting circadian effects, as well as probabilistically repetitive disturbances, i.e., meals and exercise following a similar pattern from day to day but with significant statistical variability. We develop mechanisms for comprehensively analyzing retrospective CGM, insulin, and meal data, and then (i) extracting estimates of the unknown disturbances that create otherwise unexplained blood glucose variability and (ii) using these estimates in computing an optimal set of insulin treatment parameters that resolve issues related to maladapted basal dosing and/or maladapted mealtime dosing.
The two main steps listed above, estimating the unknown disturbances and then optimizing treatment parameters, distinguish our approach from prior work on adaptive treatment of diabetes using iterative learning control (ILC) and/or run-to-run (R2R) control. (For an overview of ILC, R2R, and related methods we refer the reader to Zhang et al. (2008) , Lee and Lee (2007) , and Shen and Wang (2014) .) To discuss the prior work as it relates to diabetes, Zisser et al. (2005) ; Owens et al. (2006); Palerm et al. (2007 Palerm et al. ( , 2008 have explored the use fingerstick measurements (self monitoring of blood glucose (SMBG)), meal, and insulin delivery data to incrementally learn insulin bolus strategies and basal profiles via R2R that adapt treatment parameters to (i) the patient's meal behavior and (ii) circadian fluctuation in insulin resistance (e.g., dawn phenomenon). More recently, Herrero et al. (2015) have combined R2R with case-based reasoning (CBR) to tune the parameters that govern bolus strategies that involve classifying the current bolus scenario as an example of a previously observed "case". Incremental R2R methods have been developed to address the joint problem of basalbolus optimization in SMBG-based therapy with multiple daily injections (MDI), cf. Tuo et al. (2015) . Focusing on basal profile optimization, Toffanin et al. (2014) develop a CGM-based R2R approach for minimizing excursions above or below a preset target range. The ILC and R2R methods previously considered are generally designed to make a series of incremental steps toward a local extremum with each new data record. In contrast, our system uses multiple data records to develop an explicit model of the underlying disturbance process and then approximates a globally optimal solution in one large step.
To outline the sequel, Section 2 defines the retrospective optimization problem in general terms, pointing out that closed-form solutions generally do not exist. Section 3 presents a heuristic solution to the retrospective optimization problem and illustrates the method using data collected in a 30-day field study of patients with T1D. Section 4 presents the results of an in silico preclinical trial showing that the heuristic solution is capable of improving glycemic outcomes in a population of patients on "open loop" functional insulin therapy.
RETROSPECTIVE OPTIMIZATION OF CONTROL PARAMETERS USING SAMPLES OF A REGENERATIVE DISTURBANCE PROCESS
We assume that the process can be modeled as a discretetime linear time invariant system:
where A, B, G, H, C are state space matrices, X(k) ∈ n is the state vector of the process (where X(k) = 0 corresponds to the nominal operating point of the system); Y (k) ∈ is the measured response (i.e. process output variable); U (k) ∈ is a control input vector; ∆(k) ∈ is an observed disturbance process (whose value at stage k can inform the control action taken in that stage); and Ω(k) ∈ is an unobserved disturbance process (whose values can only be inferred after the control action take in stage k). We assume that ∆ and Ω are both regenerative processes, such that∆ 0 ,∆ 1 , . . . are independent and identically distributed (i.i.d.) and Ω 0 ,Ω 1 , . . . are also i.i.d., wherẽ
(In other words, the processes ∆ and Ω probabilistically renew every T stages.) The controller has access to a noisy measurement of the observable disturbance process
along with access to a noisy measurement of the response variable Y (k):
where N proc (k) and N meas (k) are i.i.d.
We assume further that the control actions taken at stage k are a function of Y obs (k) and ∆ obs (k):
where τ (k) = k mod T is an index into the current Tlength regenerative cycle of the ∆ and Ω processes and Θ = {θ 1 (τ ), θ 2 (τ ), θ 3 (τ )} T −1 τ =0 are "functional process control" parameters to be optimized. The objective of parameter optimization is to minimize the the average rate of cost accrual:
where r(Y ) is a nonnegative "risk" function that quantifies the cost of the response Y . (We assume for now that the limit exists.)
Note that with the assumptions that the processes ∆ and Ω are regenerative and that the processes N proc and N meas are i.i.d. the state trajectory of the system can be described (using the discrete time Lagrange formula) as a linear system driven by a regenerative process as follows:
where A CL accounts for closed-loop dynamic of the functional process control law and
is a regenerative process that accounts for the affect of ∆, Ω, N proc , and
Expected Average Cost and Average Cost Per Cycle
to be the average accumulated cost associated with the d-th regenerative cycle, so that
We can express the optimization problem of (4) equivalently as
Note that, even though the disturbance process is regenerative, the response of the linear system to the regenerative disturbance is not. Specifically,X 0 ,X 1 ,X 2 , . . . are not independent, since generally X((d + 1)T ) (the first element ofX d+1 ) is correlated to X(dT + T − 1) (the last element ofX d ) through (1). By the same token,
On the other hand, given the dependance of X(dT ) on only X((d − 1)T ), the process {X(dT )} d can be thought of as a IFAC DYCOPS-CAB, 2016 June 6-8, 2016 Markov process on a general state-space S. Furthermore, given the stability of the closed-loop control (Eq. 5), the Markov chain is Harris recurrent, leading to the following Conjecture 1. If (A CL , B CL ) from (5) is stable, then X(dT ) converges almost surely to a limiting random variable X(∞T ), and
in expectation as D → ∞, where X(∞T, 0), X(∞T, 1), . . . are independent realizations of X(∞T ).
Given that the conjecture is true, we could infer that, since R(X(∞T, 0),Ξ 0 ), R(X(∞T, 1),Ξ 1 ), . . . are i.i.d., the right hand side of (6) is guaranteed by the strong law of large numbers to converge to E{R(X(∞T ),Ξ)} as D → ∞. Thus, the limit in the definition of our objective function would be guaranteed to exist.
Retrospective Optimization
Having independent samplesξ 0 ,ξ 1 , . . . ,ξ S of the first S +1 regenerative disturbance process vectorsΞ 0 ,Ξ 1 , . . . ,Ξ S , we may take 1
as an approximation of the objective function in (4), so that
is an approximate solution to the functional process control problem.
As each new sampleξ 0 ,ξ 1 , . . . arrives, the solution to (7) can be recomputed as a form of indirect adaptive control in sense the empirical distribution of represented by the collection of samplesξ 0 ,ξ 1 , . . . ,ξ S eventually recreates the unknown distribution from which they are derived.
As in the related literature on direct optimization of gain matrices with or without sparseness or other constraints, e.g., Choi and Sirisena (1974) ; Wenk and Knapp (1980); Fardad et al. (2009) , closed-form solutions to (7) generally do not exist, even for deterministic problems with quadratic control criteria, and gradient-based methods for optimizing feedback parameters are the typical approach. For our stochastic formulation, a systematic approach may lie in the direction of stochastic gradient methods for "search in policy space" that take advantage of the regenerative structure of the disturbance function, as in Marbach and Tsitsiklis (2003).
Discussion
The basic framework above assumes that control actions are computed per (3), where corrective actions are linear with respect to both the immediate observation Y obs (k) and the observed disturbance function ∆ obs (k). In many applications, these feedback and feedforward components of the control signal may not apply at every stage. (This would be the case, for example, in functional insulin therapy, where proactive insulin actions will be taken at random times (e.g., mealtimes) or under prescribed conditions (e.g., BG above or below thresholds).) Additionally, control actions may be computed as a function of the current estimate of the state of the process using a Kalman filter or other observer. In both cases, the retrospective optimization framework above would continue to apply as long as final closed-loop dynamic can ultimately be expressed as a stable dynamic system driven by a regenerative disturbance process.
RETROSPECTIVE PROFILE OPTIMIZATION IN TYPE 1 DIABETES
Here we present an algorithm for the retrospective optimization problem of Section 2.2 as applied to functional insulin therapy in T1D, where the risk function r used in the optimization model (4) reflects the asymmetry of clinical risk associated with hypo-and hyperglycemic excursions from euglycemia, as in "risk space" approach of Kovatchev et al. (2001) . More specifically, we seek to minimize a log-of-quadratic risk function that attributes equal clinical risk to a threshold low glucose concentration BG lo and a threshold high glucose concentration BG hi , and where risk levels increase sharply for glucose concentrations below BG lo and increase less sharply above BG hi . While stochastic gradient methods could be applied to this problem in general and may converge to local extrema, a convenient method of estimating the gradient sample data remains to be developed. For this reason, our preliminary work has focused on the development of a heuristic procedure.
The resulting Retrospective Profile Optimization procedure operates on open-loop data collected from the patient over the course of two-to-four weeks. Specifically, the procedure assumes access to the following biometric parameters associated with the patient: (1) percentage glycated hemoglobin A1C (HbA1c), (2) body weight (kg), (3) typical basal rate pattern (U/hr), (4) typical insulin sensitivity factor profile, otherwise known as the Correction Factor (CF) profile, (mg/dl/U), and (5) typical Carbohydrate Ratio (CR) profile (gCHO/U), all of which can be obtained from the patient at a screening visit prior to the implementation of the algorithm. In addition, the optimization procedure relies on the collection of openloop data from the patient: (1) continuous glucose monitoring data relative to fasting BG (serving as Y obs (k)), (2) basal and bolus insulin delivery data relative to basal insulin delivery (informing U (k)), and (3) meal data in grams CHO (serving as the observed disturbance ∆ obs (k)).
The optimization procedure works in two main steps:
1. Estimation of Disturbance Process Samples -Here, the procedure estimates samplesξ 0 ,ξ 1 , . . . of the daily regenerative disturbance process via a "net effect" calculation similar to the computation presented in Patek et al. (2016) ; Kovatchev et al. (2015) . The key idea of this process is to invert a patient-specific mathematical model to estimate the additional differential glucose rate-of-appearance IFAC DYCOPS-CAB, 2016 June 6-8, 2016 . NTNU, Trondheim, Norway net effect signal needed to reconcile the CGM data with recorded meal and insulin inputs. Intuitively, if the CGM record shows a large positive transient at a given time of the day and if the insulin pump record shows a large positive deviation from basal insulin delivery at the same time (e.g., a bolus) and if the patient estimates a carbohydrate load in grams CHO, then through a mathematical model of the patient, we can quantitatively assess the differential glucose rate-of-appearance needed to achieve a fit between model-predicted and actual interstitial BG. If the meal is not acknowledged, then the differential rateof-appearance net effect signal represents the whole rateof-appearance profile associated with the meal. If the meal is acknowledged but the carbohydrate load is under-(or over-) estimated, then the differential rate-of-appearance signal represents the supplemental (or deficit) impact of the actual meal. Conversely, if there is a time of the day where BG drops suddenly, then this can be explained through a negative net effect signal at the same time.
(Here, negative-valued net effects serve as signature or marker for exercise or enhanced insulin sensitivity.) An important feature of the net effect signals computed this way is that once a net effect trace has been computed, it can be "fed" back into the mathematical model along with the original record of insulin delivery and meals to reproduce a close approximation to the original CGM record for that day as described in Patek et al. (2016) .
Identification of BG Risk Zones and Iterative
Adjustment of Therapy Parameters -Here, the procedure iteratively identifies periods of hypo-and hyper-glycemic risk, focusing on intervals of the 24-hour day where the risk is both significant and also one-sided in the sense that the historical record shows only hypo-or only hyper-glycemic risk during that time of the day. The computation derives from the internal assessment of a 24-hour hypoglycemia risk profile computed as the multi-day average of movingwindow averages of hypoglycemia risk r lo (y) (taking the value of the risk function r for BG levels y below euglycemia and zero otherwise), along with an analogous 24-hour hyperglycemia risk profile. By construction, the risk profiles are such that if a profile vales exceeds unity, then the patient is either consistently experiencing BG below BG lo or above BG hi at that time of the day, respectively, or the historical record demonstrates several examples of profound out of range excursions. (The top panels of Figs. 2 and 4 show examples of hyperglycemia and hypoglycemia risk profiles in retrospective data. The hyperglycemia risk profile is plotted above the x-axis and the area under the curve is shaded in dark blue, and the hypoglycemia risk profile is plotted as a negative risk value and is shaded in light blue.) Having identified the risk zones to address (if any), the procedure uses the ability to replay the historical record with combinations of percentage adjustments to basal, correction factor, and carbohydrate ratio profiles.
The output of the procedure is a CSII profile recommendation constrained to lie within 25% of the original (preprogrammed) profile value. (Changes of more than 25% to any basal, correction factor, and carbohydrate ratio value are not allowed.)
Compared to the basal initialization algorithm presented in Dassau et al. (0) , the system presented in this paper is designed to jointly optimize basal and bolus parameters.
In addition, the current system (i) parameterizes net effect as a differential rate-of-appearance signal (as opposed to an an oral carbohydrate signal) and (ii) optimizes profile values against the ensemble of net effect traces from the open-loop data (as opposed to optimizing insulin delivery each day and then recommending the median change).
To illustrate the treatment optimization heuristic we retrospectively apply it to data from a 30-day field study (phase 1 of NIH/NIDDK RO1 DK 085623), focusing particularly on Subject 5001. Fig. 1 shows smoothed and gap-interpolated CGM data from Subject 5001. Note that the patient exhibits significant day-to-day variability throughout the 24-hour period from midnight-to-midnight, especially in the time period from 5AM to 10AM, where examples of both profound hyperglycemia and profound hypoglycemia can be found.
The data also show a significant and fairly consistent trend toward low blood glucose between 3PM and 8PM. Fig. 1 .) The top panel of the figure shows normalized hyperglycemic risk (dark blue) and hypoglycemic risk (light blue) profiles. The goal of insulin profile optimization is to update the patient's pump parameters to minimize the total area between these two risk profiles.
Note that the open loop data shows a consistent trend toward hypoglycemia between 3PM and 8PM as well as a very wide spread of BG between 5AM-8AM, indicating that little can be done to improve BG outcomes in this timeframe at least purely through adjustment of insulin pump parameters. response to the recognizable hypoglycemia risk between 3PM and 8PM illustrated in Fig. 2 . 4 shows the risk profile assessment for Subject 5001 using a replay simulation of the patient's data using the optimized insulin pump parameters. Note that the replay simulation shows a significant reduction in total risk between 3PM and 8PM resulting from the fact the patient would be taking less basal, correction, and meal insulin in the timeframe between 9AM and 5PM.
IN SILICO PRECLINICAL TRIALS
To give a preliminary view to the efficacy of the method we present the results of an in silico preclinical trial (cf. Patek et al. (2009) ) in which 100 in silico adult subjects are simulated using either their individually optimized CSII parameters (basal rates, carbohydrate ratios, and correction factors) or maladapted parameters over periods 
DISCUSSION
We have presented a novel approach to data-driven optimization of insulin pump treatment parameters in T1D. The underlying methodology takes advantage of the richness of CGM data in explicitly estimating samples of the unknown disturbance process that is responsible for the significant BG fluctuations observed in daily life. The heuristic Retrospective Profile Optimization routine of Section 3 serves to optimize the parameters of functional insulin therapy (i.e. the patient's basal rate, correction factor, and carbohydrate ratio profiles) against the ensemble of estimated disturbance process samples. The in silico pre-clinical trial results presented in Section 4 demonstrate the potential effectiveness of the method in improving treatment for patients using suboptimal treatment parameters.
